Investing.com - Incyte (NASDAQ:INCY) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Incyte announced earnings per share of $0.65 on revenue of $579.4M. Analysts polled by Investing.com anticipated EPS of $0.35 on revenue of $576.62M. That with comparison to EPS of $0.32 on revenue of $528.4M in the same period a year before.Incyte had reported EPS of $0.59 on revenue of $551.58M in the previous quarter.Analysts are expecting EPS of $0.31 and revenue of $550.49M in the upcoming quarter.
Incyte shares are down 13.16% from the beginning of the year and are trading at $75.83 , down-from-52-week-high.They are under-performing the Nasdaq which is up 7.59% year to date.
Incyte follows other major Healthcare sector earnings this month
Incyte's report follows an earnings beat by J&J on Wednesday, January 22, 2020, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday, January 29, 2020 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar